Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women

Dora Berman-Weinberg, Barbara J. Nicklas, Ellen M. Rogus, Karen E. Dennis, Andrew R. Goldberg

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

In women there is an increase in visceral obesity, subcutaneous abdominal adipocyte lipolysis, and risk of cardiovascular disease (CVD) associated with weight gain after menopause. The mechanisms underlying this increase in adrenoreceptor (AR)-agonist catecholamine-stimulated lipolysis and abdominal obesity in postmenopausal women were studied in intact adipocytes isolated from the abdominal and gluteal subcutaneous fat depots in 19 obese (48% ± 1% body fat, mean ± SE) women with a mean ± SE age of 58 ± 1 years. The fat cell size and adipose tissue lipoprotein lipase (ATLPL) activity were similar in both sites. The maximal lipolytic responsiveness and sensitivity to isoproterenol were higher (P < .05) in abdominal compared with gluteal adipocytes, but maximal lipolytic response to a post-AR agent was similar. Abdominal adipocytes had a higher β-AR ([3H]-CGP-12177) and αz- AR ([3H]-yohimbine) affinity than gluteal cells (P < .05), lower α2-AR density (P < .05), but similar β-AR density as gluteal cells. Both abdominal and gluteal cell size correlated with α2-AR density (P < .01), but not with β-AR density. Thus, a higher β-AR affinity and lower α2-AR relative to β-AR density may explain the higher in vitro catecholamine-mediated lipolysis in abdominal compared with gluteal adipocytes in obese, postmenopausal women.

Original languageEnglish
Pages (from-to)467-473
Number of pages7
JournalMetabolism: Clinical and Experimental
Volume47
Issue number4
DOIs
StatePublished - May 5 1998
Externally publishedYes

Fingerprint

Lipolysis
Adipocytes
Adrenergic Receptors
Abdominal Obesity
Cell Size
Catecholamines
Adipose Tissue
Abdominal Subcutaneous Fat
Yohimbine
Lipoprotein Lipase
Menopause
Isoproterenol
Weight Gain
Cardiovascular Diseases

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women. / Berman-Weinberg, Dora; Nicklas, Barbara J.; Rogus, Ellen M.; Dennis, Karen E.; Goldberg, Andrew R.

In: Metabolism: Clinical and Experimental, Vol. 47, No. 4, 05.05.1998, p. 467-473.

Research output: Contribution to journalArticle

Berman-Weinberg, Dora ; Nicklas, Barbara J. ; Rogus, Ellen M. ; Dennis, Karen E. ; Goldberg, Andrew R. / Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women. In: Metabolism: Clinical and Experimental. 1998 ; Vol. 47, No. 4. pp. 467-473.
@article{7709d652443f4a428502b62b1c3845ed,
title = "Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women",
abstract = "In women there is an increase in visceral obesity, subcutaneous abdominal adipocyte lipolysis, and risk of cardiovascular disease (CVD) associated with weight gain after menopause. The mechanisms underlying this increase in adrenoreceptor (AR)-agonist catecholamine-stimulated lipolysis and abdominal obesity in postmenopausal women were studied in intact adipocytes isolated from the abdominal and gluteal subcutaneous fat depots in 19 obese (48{\%} ± 1{\%} body fat, mean ± SE) women with a mean ± SE age of 58 ± 1 years. The fat cell size and adipose tissue lipoprotein lipase (ATLPL) activity were similar in both sites. The maximal lipolytic responsiveness and sensitivity to isoproterenol were higher (P < .05) in abdominal compared with gluteal adipocytes, but maximal lipolytic response to a post-AR agent was similar. Abdominal adipocytes had a higher β-AR ([3H]-CGP-12177) and αz- AR ([3H]-yohimbine) affinity than gluteal cells (P < .05), lower α2-AR density (P < .05), but similar β-AR density as gluteal cells. Both abdominal and gluteal cell size correlated with α2-AR density (P < .01), but not with β-AR density. Thus, a higher β-AR affinity and lower α2-AR relative to β-AR density may explain the higher in vitro catecholamine-mediated lipolysis in abdominal compared with gluteal adipocytes in obese, postmenopausal women.",
author = "Dora Berman-Weinberg and Nicklas, {Barbara J.} and Rogus, {Ellen M.} and Dennis, {Karen E.} and Goldberg, {Andrew R.}",
year = "1998",
month = "5",
day = "5",
doi = "10.1016/S0026-0495(98)90061-0",
language = "English",
volume = "47",
pages = "467--473",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women

AU - Berman-Weinberg, Dora

AU - Nicklas, Barbara J.

AU - Rogus, Ellen M.

AU - Dennis, Karen E.

AU - Goldberg, Andrew R.

PY - 1998/5/5

Y1 - 1998/5/5

N2 - In women there is an increase in visceral obesity, subcutaneous abdominal adipocyte lipolysis, and risk of cardiovascular disease (CVD) associated with weight gain after menopause. The mechanisms underlying this increase in adrenoreceptor (AR)-agonist catecholamine-stimulated lipolysis and abdominal obesity in postmenopausal women were studied in intact adipocytes isolated from the abdominal and gluteal subcutaneous fat depots in 19 obese (48% ± 1% body fat, mean ± SE) women with a mean ± SE age of 58 ± 1 years. The fat cell size and adipose tissue lipoprotein lipase (ATLPL) activity were similar in both sites. The maximal lipolytic responsiveness and sensitivity to isoproterenol were higher (P < .05) in abdominal compared with gluteal adipocytes, but maximal lipolytic response to a post-AR agent was similar. Abdominal adipocytes had a higher β-AR ([3H]-CGP-12177) and αz- AR ([3H]-yohimbine) affinity than gluteal cells (P < .05), lower α2-AR density (P < .05), but similar β-AR density as gluteal cells. Both abdominal and gluteal cell size correlated with α2-AR density (P < .01), but not with β-AR density. Thus, a higher β-AR affinity and lower α2-AR relative to β-AR density may explain the higher in vitro catecholamine-mediated lipolysis in abdominal compared with gluteal adipocytes in obese, postmenopausal women.

AB - In women there is an increase in visceral obesity, subcutaneous abdominal adipocyte lipolysis, and risk of cardiovascular disease (CVD) associated with weight gain after menopause. The mechanisms underlying this increase in adrenoreceptor (AR)-agonist catecholamine-stimulated lipolysis and abdominal obesity in postmenopausal women were studied in intact adipocytes isolated from the abdominal and gluteal subcutaneous fat depots in 19 obese (48% ± 1% body fat, mean ± SE) women with a mean ± SE age of 58 ± 1 years. The fat cell size and adipose tissue lipoprotein lipase (ATLPL) activity were similar in both sites. The maximal lipolytic responsiveness and sensitivity to isoproterenol were higher (P < .05) in abdominal compared with gluteal adipocytes, but maximal lipolytic response to a post-AR agent was similar. Abdominal adipocytes had a higher β-AR ([3H]-CGP-12177) and αz- AR ([3H]-yohimbine) affinity than gluteal cells (P < .05), lower α2-AR density (P < .05), but similar β-AR density as gluteal cells. Both abdominal and gluteal cell size correlated with α2-AR density (P < .01), but not with β-AR density. Thus, a higher β-AR affinity and lower α2-AR relative to β-AR density may explain the higher in vitro catecholamine-mediated lipolysis in abdominal compared with gluteal adipocytes in obese, postmenopausal women.

UR - http://www.scopus.com/inward/record.url?scp=0031891324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031891324&partnerID=8YFLogxK

U2 - 10.1016/S0026-0495(98)90061-0

DO - 10.1016/S0026-0495(98)90061-0

M3 - Article

VL - 47

SP - 467

EP - 473

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 4

ER -